ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation
Sponsored by Adrien Schwitzguebel
About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Lesion of the ECRB tendon on ultrasonography ([hypoechogenic area during rest OR hypoechogenic area during active contraction, OR compressibility of the tendon OR doppler signal] AND [positive sonopalpation])
- Failure to rehabilitation program including shockwave therapy defined as the need for the patient undergoing additional therapies
Exclusion Criteria
- Presence on ultrasound of an isolated lesion of the superficial epicondylar tendons as described above, with intact ECRB
- Presence on ultrasound of any of: radiohumeral synovial material; interruption of the lateral collateral ligament; radial nerve entrapment, i.e. under the arcade of Frohse; osteochondral lesion; joint effusion. Note: calcic enthesophytes are not considered as an exclusion criteria
- Clinical presence of cervicobrachialgia, or pain irradiating into the hand
- Corticosteroids: oral intake or infiltration on the last 3 months
- Proximal radius fracture history
- Active inflammatory rheumatic disorders
- Diabetes mellitus
- Immunocompromized status
- Allergy to local anesthetics
- Bleeding disorders or current anticoagulation therapy
- Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiopulmonary significant insufficiency, etc.)
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- Participation in another study with investigational drug within the 30 days preceding and during the present study
- Previous enrolment into the current study
- Enrolment of the investigator, his/her family members, employees and other dependent persons